maintenance on tirzepatide Zepbound Dose After Goal Weight: Next Steps TIRZEPATIDE & DETERMINATION / MAINTENANCE

2022 Sep;10(6):1134-1142

Patients receiving GLP-1 receptor agonists had a significantly lower need for endoscopic pancreatic interventions

Although fundamental 5A-1MQ and LD-mediated changes to the microbiome were identified, this work is similar to many current studies where further investigations will clarify if changes in the microbiome are causative or associative 100

Vrkonyi TT, Psa A, Pv N, Pavo I

FDA determined on December 19, 2024 that the tirzepatide injection shortage was resolved, and on February 21, 2025 that the semaglutide injection shortage was resolved

The results were unlike anything shed tried before